04/23/2024
3:32 PM | Xeris Biopharma (Filer)
| Form ARS | |
04/23/2024
3:24 PM | Xeris Biopharma (Filer)
| Form DEF 14A | |
04/23/2024
3:26 PM | Xeris Biopharma (Filer)
| Form DEFA14A | |
04/11/2024
3:05 PM | SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:43 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
4:45 PM | Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:32 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/14/2024
8:03 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:19 PM | Xeris Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
6:27 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
4:04 PM | Edick Paul R (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:04 PM | Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:04 PM | JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:05 PM | Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:05 PM | Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:09 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:16 PM | Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:20 PM | HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:35 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:58 PM | Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
6:20 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
6:12 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:55 PM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:11 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
5:57 PM | Edick Paul R (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:23 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:28 PM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:52 PM | SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:55 PM | Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:56 PM | PERSKY MARLA (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:58 PM | HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:59 PM | JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:00 PM | Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:02 PM | BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting)
Xeris Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:35 PM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
3:31 PM | Xeris Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:21 AM | Xeris Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
